Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension

被引:24
|
作者
Suresh, Karthik [1 ]
Servinsky, Laura [1 ]
Jiang, Haiyang [1 ]
Bigham, Zahna [1 ]
Zaldumbide, Joel [1 ]
Huetsch, John C. [1 ]
Kliment, Corrine [1 ]
Acoba, Michelle G. [2 ]
Kirsch, Brian J. [3 ]
Claypool, Steven M. [2 ]
Le, Anne [3 ]
Damarla, Mahendra [1 ]
Shimoda, Larissa A. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
关键词
calcium; endothelium; mitochondria; PAH; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; ROS GENERATION; CALCIUM INFLUX; COMPLEX-III; FISSION; TRPV4; DRP1; DYSFUNCTION; PHOSPHORYLATION;
D O I
10.1152/ajplung.00396.2018
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pulmonary arterial hypertension (PAH) is a morbid disease characterized by progressive right ventricle (RV) failure due to elevated pulmonary artery pressures (PAP). In PAH, histologically complex vaso-occlusive lesions in the pulmonary vasculature contribute to elevated PAP. However, the mechanisms underlying dysfunction of the microvascular endothelial cells (MVECs) that comprise a significant portion of these lesions are not well understood. We recently showed that MVECs isolated from the Sugen/hypoxia (SuHx) rat experimental model of PAH (SuHx-MVECs) exhibit increases in migration/proliferation, mitochondrial reactive oxygen species (ROS; mtROS) production, intracellular calcium levels ([Ca2+](i)), and mitochondrial fragmentation. Furthermore, quenching mtROS with the targeted antioxidant MitoQ attenuated basal [Ca2+](i), migration and proliferation; however, whether increased mtROS-induced [Ca2+](i) entry affected mitochondrial morphology was not clear. In this study, we sought to better understand the relationship between increased ROS, [Ca2+](i), and mitochondrial morphology in SuHx-MVECs. We measured changes in mitochondrial morphology at baseline and following inhibition of mtROS, with the targeted antioxidant MitoQ, or transient receptor potential vanilloid-4 (TRPV4) channels, which we previously showed were responsible for mtROS-induced increases in [Ca2+](i) in SuHx-MVECs. Quenching mtROS or inhibiting TRPV4 attenuated fragmentation in SuHx-MVECs. Conversely, inducing mtROS production in MVECs from normoxic rats (N-MVECs) increased fragmentation. Ca2+ entry induced by the TRPV4 agonist GSK1017920A was significantly increased in SuHx-MVECs and was attenuated with MitoQ treatment, indicating that mtROS contributes to increased TRPV4 activity in SuHx-MVECs. Basal and maximal respiration were depressed in SuHx-MVECs, and inhibiting mtROS, but not TRPV4, improved respiration in these cells. Collectively, our data show that, in SuHx-MVECs, mtROS production promotes TRPV4-mediated increases in [Ca2+](i), mitochondrial fission, and decreased mitochondrial respiration. These results suggest an important role for mtROS in driving MVEC dysfunction in PAH.
引用
收藏
页码:L639 / L652
页数:14
相关论文
共 50 条
  • [1] Aquaporin 1 mediates microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary hypertension
    Yun, Xin
    Philip, Nicolas M.
    Jiang, Haiyang
    Smith, Zion
    Huetsch, John
    Mahendra, Damarla
    Suresh, Karthik
    Shimoda, Larissa
    FASEB JOURNAL, 2022, 36
  • [2] Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension
    Kojonazarov, Baktybek
    Hadzic, Stefan
    Ghofrani, Hossein Ardeschir
    Grimminger, Friedrich
    Seeger, Werner
    Weissmann, Norbert
    Schermuly, Ralph Theo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (04) : 515 - 518
  • [3] Contribution of stem-like cells to angioproliferative pulmonary arterial hypertension in the SU5416/chronic hypoxia model
    Farkas, Laszlo
    Farkas, Daniela
    Kraskauskas, Donatas
    Alhussaini, Aysar
    Kraskauskiene, Vita
    Bogaard, Harm
    Voelkel, Norbert
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] Thioridazine Improves Pulmonary Arterial Pressure In The Su5416/chronic Hypoxia Rat Model Of Severe Pulmonary Arterial Hypertension
    Foster, W. S.
    Deng, Y.
    Taha, M.
    Stewart, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model
    Sanada, Takayuki J.
    Hosomi, Koji
    Shoji, Hiroki
    Park, Jonguk
    Naito, Akira
    Ikubo, Yumiko
    Yanagisawa, Asako
    Kobayashi, Takayuki
    Miwa, Hideki
    Suda, Rika
    Sakao, Seiichiro
    Mizuguchi, Kenji
    Kunisawa, Jun
    Tanabe, Nobuhiro
    Tatsumi, Koichiro
    PULMONARY CIRCULATION, 2020, 10 (03)
  • [6] Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model
    Bikou, Olympia
    Hajjar, Roger J.
    Hadri, Lahouaria
    Sassi, Yassine
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (160): : 1 - 9
  • [7] The Effects of Antiangiogenic Compound SU5416 in a Rat Model of Pulmonary Arterial Hypertension
    Sakao, Seiichiro
    Tatsumi, Koichiro
    RESPIRATION, 2011, 81 (03) : 253 - 261
  • [8] Partially hydrolyzed guar gum suppresses the progression of pulmonary arterial hypertension in a SU5416/hypoxia rat model
    Sanada, Takayuki J.
    Hosomi, Koji
    Park, Jonguk
    Naito, Akira
    Sakao, Seiichiro
    Tanabe, Nobuhiro
    Kunisawa, Jun
    Tatsumi, Koichiro
    Suzuki, Takuji
    PULMONARY CIRCULATION, 2023, 13 (03)
  • [9] Pulmonary Emphysema in Rats with Severe Pulmonary Hypertension Induced by SU5416 and Hypoxia
    Kojonazarov, B.
    Hadzic, S.
    Ghofrani, H. A.
    Grimminger, F.
    Weissmann, N.
    Seeger, W.
    Schermuly, R. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] Outcomes of pregnancy in mice with pulmonary hypertension induced by Hypoxia/SU5416
    Liu, Yang
    Deng, Jing
    Zhao, Yichen
    Liu, Kemin
    Zhang, Wenbo
    Wang, Qiang
    Wang, Jiangang
    Piao, Chunmei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 669 : 128 - 133